164 related articles for article (PubMed ID: 38378007)
1. Linear IgA bullous dermatosis of childhood: Retrospective single-center cohort.
Wang KL; Lehman JS; Davis DMR
Pediatr Dermatol; 2024; 41(3):461-464. PubMed ID: 38378007
[TBL] [Abstract][Full Text] [Related]
2. Linear IgA bullous dermatosis in adults and children: a clinical and immunopathological study of 38 patients.
Genovese G; Venegoni L; Fanoni D; Muratori S; Berti E; Marzano AV
Orphanet J Rare Dis; 2019 May; 14(1):115. PubMed ID: 31126328
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of a case of idiopathic linear IgA bullous dermatosis with oral sulfasalazine.
Yang Z; Liu ZH; Sun CQ; Shen H
Dermatol Ther; 2020 Mar; 33(2):e13210. PubMed ID: 31895494
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced Linear IgA Bullous Dermatosis: A Case Report and Review of the Literature.
Lammer J; Hein R; Roenneberg S; Biedermann T; Volz T
Acta Derm Venereol; 2019 May; 99(6):508-515. PubMed ID: 30809685
[TBL] [Abstract][Full Text] [Related]
5. Linear IgA Bullous Dermatosis: A Series of 17 Cases.
Díaz MS; Morita L; Ferrari B; Sartori S; Greco MF; Sobrevias Bonells L; González-Enseñat MA; Vicente Villa MA; Larralde M
Actas Dermosifiliogr (Engl Ed); 2019 Oct; 110(8):673-680. PubMed ID: 31014539
[TBL] [Abstract][Full Text] [Related]
6. Disseminated Tuberculosis in a Nigerian Adolescent with Linear IgA Bullous Dermatosis: A Case Report and Review of Literature.
Gobir AA; Ariyibi SO; Ibraheem RM; Johnson AR; Abdulkadir MB; Katibi OS; Adeoye PO; Udoh EA; Ilesanmi ON; Folaranmi OO
West Afr J Med; 2022 Jun; 39(6):646-650. PubMed ID: 35752975
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and Comparison of Clinical and iLaboratory Characteristics of Patients With IgA Epidermolysis Bullosa Acquisita, Linear IgA Bullous Dermatosis, and IgG Epidermolysis Bullosa Acquisita.
Becker M; Schumacher N; Schmidt E; Zillikens D; Sadik CD
JAMA Dermatol; 2021 Aug; 157(8):917-923. PubMed ID: 34160564
[TBL] [Abstract][Full Text] [Related]
8. Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms.
Chanal J; Ingen-Housz-Oro S; Ortonne N; Duong TA; Thomas M; Valeyrie-Allanore L; Lebrun-Vignes B; André C; Roujeau JC; Chosidow O; Wolkenstein P
Br J Dermatol; 2013 Nov; 169(5):1041-8. PubMed ID: 23815152
[TBL] [Abstract][Full Text] [Related]
9. Flame figures in linear IgA bullous dermatosis: a novel histopathologic finding.
Fulton E; Jan F; Zimarowski MJ
Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447641
[TBL] [Abstract][Full Text] [Related]
10. Neonatal linear immunoglobulin a bullous dermatosis: a rare presentation.
Julapalli MR; Brandon KL; Rosales CM; Grover RK; Plunkett RW; Metry DW
Pediatr Dermatol; 2012; 29(5):610-3. PubMed ID: 21906150
[TBL] [Abstract][Full Text] [Related]
11. Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time.
Koga H; Ishii N; Hashimoto T; Nakama T
J Dermatol; 2017 Feb; 44(2):189-193. PubMed ID: 28497856
[TBL] [Abstract][Full Text] [Related]
12. Neonatal Linear IgA Bullous Dermatosis Mediated by Breast Milk-Borne Maternal IgA.
Egami S; Suzuki C; Kurihara Y; Yamagami J; Kubo A; Funakoshi T; Nishie W; Matsumura K; Matsushima T; Kawaida M; Sakamoto M; Amagai M
JAMA Dermatol; 2021 Sep; 157(9):1107-1111. PubMed ID: 34259802
[TBL] [Abstract][Full Text] [Related]
13. Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults.
Gottlieb J; Ingen-Housz-Oro S; Alexandre M; Grootenboer-Mignot S; Aucouturier F; Sbidian E; Tancrede E; Schneider P; Regnier E; Picard-Dahan C; Begon E; Pauwels C; Cury K; Hüe S; Bernardeschi C; Ortonne N; Caux F; Wolkenstein P; Chosidow O; Prost-Squarcioni C
Br J Dermatol; 2017 Jul; 177(1):212-222. PubMed ID: 27995619
[TBL] [Abstract][Full Text] [Related]
14. Linear IgA bullous dermatosis in an acute myeloid leukemia patient: a rare case report.
Kianindra DV; Rosa A; Pebriany D; Dewiyanti W; Madjid A
Acta Dermatovenerol Alp Pannonica Adriat; 2023 Mar; 32(1):19-22. PubMed ID: 36945763
[TBL] [Abstract][Full Text] [Related]
15. Linear IGA bullous dermatosis potentially triggered by vaccination.
Corrà A; Bonciolini V; Quintarelli L; Verdelli A; Caproni M
Int J Immunopathol Pharmacol; 2022; 36():20587384211021218. PubMed ID: 35001680
[TBL] [Abstract][Full Text] [Related]
16. Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
Garel B; Ingen-Housz-Oro S; Afriat D; Prost-Squarcioni C; Tétart F; Bensaid B; Bara Passot C; Beylot-Barry M; Descamps V; Duvert-Lehembre S; Grootenboer-Mignot S; Jeudy G; Soria A; Valnet-Rabier MB; Barbaud A; Caux F; Lebrun-Vignes B
Br J Clin Pharmacol; 2019 Mar; 85(3):570-579. PubMed ID: 30511379
[TBL] [Abstract][Full Text] [Related]
17. Linear immunoglobulin a bullous dermatosis: need for an agreement on diagnostic criteria.
Antiga E; Caproni M; Fabbri P
Dermatology; 2013; 226(4):329-32. PubMed ID: 23838482
[TBL] [Abstract][Full Text] [Related]
18. Linear IgA bullous dermatosis: report of five cases in Chile.
Sandoval M; Farias MM; Gonzalez S
Int J Dermatol; 2012 Nov; 51(11):1303-6. PubMed ID: 23067077
[TBL] [Abstract][Full Text] [Related]
19. A Case of Possible Concurrence of Dermatitis Herpetiformis and Linear Immunoglobulin A / Immunoglobulin G Bullous Dermatosis.
Minakawa S; Matsuzaki Y; Hashimoto T; Ishii N; Nishie W; Sawamura D
Acta Dermatovenerol Croat; 2021 Jul; 29(2):116-117. PubMed ID: 34477081
[TBL] [Abstract][Full Text] [Related]
20. A clinical and serological study of linear IgA bullous dermatosis without linear immunoglobulin deposition other than IgA at the basement membrane zone using direct immunofluorescence.
Ohata C; Ishii N; Koga H; Nakama T
Br J Dermatol; 2017 Jul; 177(1):152-157. PubMed ID: 27943257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]